Published in J Med Virol on January 01, 1981
Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection. Infect Immun (1983) 0.96
Small albumin-immunoglobulin complexes in patients with liver disease. Immunology (1983) 0.86
Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science (1970) 5.81
Biology of hepatitis B virus. Science (1981) 4.93
Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol (1987) 3.16
Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol (1986) 2.94
The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science (1986) 2.71
A new rapid method for genetic typing of human immunoglobulins. J Immunol (1968) 2.61
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science (1985) 2.47
Anaphylactoid transfusion reactions associated with anti-IgA. Lancet (1968) 2.40
State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A (1981) 2.37
Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc Natl Acad Sci U S A (1977) 2.34
Limited humoral immunity in hepatitis C virus infection. Gastroenterology (1999) 2.31
Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. J Immunol (1987) 2.25
Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science (1985) 2.18
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08
Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med (1991) 1.95
The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol (1992) 1.95
Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J Infect Dis (1989) 1.88
Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol (1972) 1.83
Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A (1982) 1.81
Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg. J Immunol (1986) 1.73
Hepatitis B virus core antigen has two nuclear localization sequences in the arginine-rich carboxyl terminus. J Virol (1991) 1.73
Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science (1972) 1.72
Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest (1990) 1.70
Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med (1975) 1.66
Immune response to hepatitis B surface antigen. Infect Immun (1975) 1.59
The serology of chronic hepatitis B infection revisited. J Clin Invest (1993) 1.54
The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol (1998) 1.52
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol (1982) 1.50
Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology (1984) 1.48
Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet (1984) 1.42
Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region. Am J Gastroenterol (2000) 1.41
Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration. Transfusion (1989) 1.38
Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A (1983) 1.37
Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly. J Biol Chem (1993) 1.36
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest (2000) 1.34
Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut (2005) 1.33
Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects. J Med Virol (1988) 1.32
Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect Immun (1994) 1.31
Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther (2001) 1.31
Serologic specificity of hun anti-IgA and its significance in transfusion. Blood (1969) 1.30
Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. J Pediatr (1989) 1.28
Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man. Hepatology (1990) 1.28
Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1. J Virol (1991) 1.28
A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease. J Med Virol (1990) 1.27
Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination. J Immunol (1990) 1.27
Nonoverlapping T and B cell determinants on an hepatitis B surface antigen pre-S(2) region synthetic peptide. J Exp Med (1986) 1.26
Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol (1990) 1.26
Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology (1994) 1.24
Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region. Proc Natl Acad Sci U S A (1985) 1.21
T- and B-cell recognition of hepatitis B viral antigens. Immunol Today (1988) 1.20
A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis (1979) 1.15
Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model. J Virol (2001) 1.15
Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology (1993) 1.14
Am(1), the first genetic marker of human immunoglobulin A. Proc Natl Acad Sci U S A (1969) 1.12
Biochemical characterization of hepatitis B surface antigen in relation to serologic activity. J Biol Stand (1976) 1.10
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity. J Immunol (1985) 1.10
A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg. J Immunol (1987) 1.08
Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J Virol (2001) 1.06
Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood (1989) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Human antibodies to human IgA globulins. Immunochemistry (1968) 1.04
Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors. Transfusion (1987) 1.04
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions. J Immunol (1985) 1.03
Hepatitis B antigen activity in protein subunits produced by sonicaation. Nat New Biol (1973) 1.02
Complex regulation of transcription from the hepatitis B virus major surface antigen promoter in human hepatoma cell lines. J Virol (1991) 1.02
Isoimmune anti-IgA causing anaphylactoid transfusion reactions. N Engl J Med (1969) 1.01
Studies on delayed hypersensitivity to hepatitis B antigen in chimpanzees. Clin Exp Immunol (1974) 1.01
Non-A, non-B hepatitis: a contemporary assessment. Haematologia (Budap) (1982) 0.99
T-cell dependence of immune response to hepatitis B antigen in mice. Nature (1975) 0.99
Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection. J Virol (2000) 0.98
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). III. Circumvention of nonresponsiveness in mice bearing HBsAg nonresponder haplotypes. J Immunol (1983) 0.96
Two distinct but overlapping antibody binding sites in the pre-S(2) region of HBsAg localized within 11 continuous residues. J Immunol (1986) 0.96
Isoantibodies to human IgM: serologic and immunochemical investigations. J Immunol (1971) 0.96
Comparative data on the detection of hepatitis-B surface antigen by six centres. Indian J Med Res (1981) 0.96
Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors. Hepatology (1993) 0.95
Characterization of hepatitis B virus major surface antigen gene transcriptional regulatory elements in differentiated hepatoma cell lines. J Virol (1989) 0.95
Evidence against recessive inheritance of susceptibility to the chronic carrier state for hepatitis B antigen. Nature (1974) 0.95
The pathogenesis of autoimmunity in New Zealand mice. Semin Arthritis Rheum (1980) 0.93
Use of polymerase chain reaction for the early detection of HIV infection in the infants of HIV-seropositive women. AIDS (1991) 0.93
Passive haemagglutination test for anti-rhinovirus antibodies. Nat New Biol (1971) 0.93
Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis. J Infect Dis (1978) 0.92
Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J Lab Clin Med (1975) 0.91
Detection of hepatitis B virus in plasma using flow cytometric analyses of polymerase chain reaction-amplified DNA incorporating digoxigenin-11-dUTP. Blood (1993) 0.90
Letter: Nonspecificity of hepatitis B antigen detected with iodine-125-labeled antibody. Science (1973) 0.90
Antibodies to IGA in pregnancy and in recipient of Rh o (D) immune globulin (human). Transfusion (1973) 0.89
An improved method for the detection of hepatitis C virus RNA in plasma utilizing heminested primers and internal control RNA. PCR Methods Appl (1993) 0.89
Hepatitis B viral nucleotide sequences in non-A, non-B or hepatitis B virus-related chronic liver disease. Hepatology (1984) 0.89
T cell differentiation and the congenitally athymic (nude) mouse. Dev Comp Immunol (1977) 0.89
Immunization with hybrid hepatitis B virus core particles carrying circumsporozoite antigen epitopes protects mice against Plasmodium yoelii challenge. Behring Inst Mitt (1997) 0.88
Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro. AIDS (1988) 0.88
Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay. Blood (1989) 0.88
Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein. Hepatology (1998) 0.88